Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 2/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | CA1 | P00915 | 8/20 | 0.41 |
| ▸ | CA2 | P00918 | 8/20 | 0.41 |
| ▸ | CA9 | Q16790 | 7/20 | 0.41 |
| ▸ | LPAR3 | Q9UBY5 | 6/20 | 0.41 |
| ▸ | LPAR2 | Q9HBW0 | 5/20 | 0.41 |
| ▸ | CA12 | O43570 | 3/20 | 0.41 |
| ▸ | CA7 | P43166 | 3/20 | 0.41 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.41 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.41 |
| ▸ | CA3 | P07451 | 2/20 | 0.41 |
| ▸ | CA4 | P22748 | 2/20 | 0.41 |
| ▸ | CA6 | P23280 | 2/20 | 0.41 |
| ▸ | CA5A | P35218 | 2/20 | 0.41 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6805213 | 1.00 | THRB (0.47) | THRBTSHRMEN1HTTKMT2A | |
| SCHEMBL9221661 | 1.00 | THRB (0.47) | THRBTSHRMEN1HTTKMT2A | |
| SCHEMBL911135 | 1.00 | THRB (0.47) | THRBTSHRMEN1HTTKMT2A | |
| SCHEMBL187269 | 1.00 | THRB (0.47) | THRBTSHRMEN1HTTKMT2A | |
| SCHEMBL21581247 | 1.00 | THRB (0.47) | THRBTSHRMEN1HTTKMT2A | |
| SCHEMBL493840 | 1.00 | THRB (0.47) | THRBTSHRMEN1HTTKMT2A | |
| SCHEMBL1149381 | 1.00 | THRB (0.47) | THRBTSHRMEN1HTTKMT2A | |
| SCHEMBL6909601 | 1.00 | THRB (0.47) | THRBTSHRMEN1HTTKMT2A | |
| SCHEMBL14688826 | 1.00 | THRB (0.47) | THRBTSHRMEN1HTTKMT2A | |
| SCHEMBL10240 | 0.97 | THRB (0.41) | THRBTSHRMEN1HTTKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8748826-B2 | Radioimaging methods using teboroxime and thallium | BIOSENSOR INTERNATIONAL GROUP, LTD. (BM) | 2014-06-10 | — | — | US | disclosed |
| US-20140037541-A1 | RADIOIMAGING METHODS USING TEBOROXIME AND THALLIUM | BIOSENSOR INTERNATIONAL GROUP LTD. (BM) | 2014-02-06 | — | — | US | disclosed |
| US-8610075-B2 | Radioimaging applications of and novel formulations of teboroxime | BIOSENSORS INTERNATIONAL GROUP LTD. (BM) | 2013-12-17 | — | — | US | disclosed |
| US-8481946-B2 | — | — | 2013-07-09 | — | — | US | disclosed |
| US-20100140483-A1 | RADIOIMAGING APPLICATIONS OF AND NOVEL FORMULATIONS OF TEBOROXIME | Spectrum Dynamics Medical Limited (VG) | 2010-06-10 | — | — | US | disclosed |
| WO-2008059489-A2 | RADIOIMAGING APPLICATIONS OF AND NOVEL FORMULATIONS OF TEBOROXIME | SPECTRUM DYNAMICS LLC (US) | 2008-05-22 | — | — | WO | disclosed |
| EP-0199260-B1 | BORONIC ACID ADDUCTS OF TECHNETIUM-99M DIOXIME COMPLEXES | E.R. Squibb & Sons, Inc. (US) | 1989-12-06 | — | — | EP | disclosed |
| US-4705849-A | Boronic acid adducts of technetium-99m dioxime complexes | E. R. SQUIBB & SONS, INC. (US) | 1987-11-10 | — | — | US | disclosed |
| EP-0199260-A2 | Boronic acid adducts of technetium-99M dioxime complexes | E.R. Squibb & Sons, Inc. (US) | 1986-10-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140037541-A1 | RADIOIMAGING METHODS USING TEBOROXIME AND THALLIUM | TPO, THRB, SLC6A12 | THRB 2/4885TSHR 51/4885MEN1 617/4885 |
| US-20100140483-A1 | RADIOIMAGING APPLICATIONS OF AND NOVEL FORMULATIONS OF TEBOROXIME | TNNI3, TNNT2, IDO1 | THRB 36/4885TSHR 254/4885MEN1 554/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.